By Erynn Gordon, MS, LCGC 23andMe’s Director of Clinical Development Testing in pregnancy can be a little overwhelming for prospective parents – blood tests, glucose challenge, ultrasounds, fetal nonstress tests....

February 28 is Rare Disease Day – a concept first initiated by the European Rare Disease Organization (EURORDIS) and now recognized around the world. Around 6,800 rare diseases have been...

Take a moment to look back at the ten most interesting and significant genetic findings of 2012 or at least the ones that drew our attention. In the last 12...

“Québécois” will likely be celebrating John the Baptist and French-Canadian heritage on June 24th with lively parties, parades and bonfires. At 23andMe we’re paying tribute to French-Canadian ancestry by highlighting the interesting history of this region and new relevant health reports.

The realization of a long-awaited hope arrived this past month for many families in the form of a new treatment for cystic fibrosis. Cystic fibrosis (CF) is one of the most common recessively inherited diseases, affecting about 30,000 people in the United States. Last month the FDA approved the drug ivacaftor (Kalydeco ®) as the first treatment to address one of the underlying causes of CF.

SNPwatch gives you the latest news about research linking various traits and conditions to individual genetic variations. These studies are exciting because they offer a glimpse into how genetics may...